Hemoglobin and iron indices in nonanemic premenopausal blood donors predict future deferral from whole blood donation

Transfusion

Volumn 51, Issue 12, 2011, Pages 2709-2713

  Pasricha, Sant Rayn ^a   McQuilten, Zoe K ^a   Keller, Anthony J ^a   Wood, Erica M ^a  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN; HEPCIDIN; IRON; TRANSFERRIN RECEPTOR;

ANEMIA; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DATA BASE; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; PREDICTIVE VALUE; PREMENOPAUSE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ANEMIA, IRON-DEFICIENCY; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD DONORS; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; IRON; MIDDLE AGED; PREMENOPAUSE; PROSPECTIVE STUDIES; RECEPTORS, TRANSFERRIN; TIME FACTORS;

EID: 83555161539     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03173.x     Document Type: Article

References (15)

1. Murray-Kolb LE, Beard JL,. Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr 2007; 85: 778-87. (Pubitemid 46393510)
2. Murray-Kolb LE, Beard JL,. Iron deficiency and child and maternal health. Am J Clin Nutr 2009; 89: 946S-50S.
3. Pena-Rosas JP, Viteri FE,. Effects of routine oral iron supplementation with or without folic acid for women during pregnancy (Cochrane Review). Cochrane Database Syst Rev 2006; 3: CD004736. 1465-858.
4. Mast AE, Schlumpf KS, Wright DJ, Custer B, Spencer B, Murphy EL, Simon TL,; NHLBI Retrovirus Epidemiology Donor Study-II. Demographic correlates of low hemoglobin deferral among prospective whole blood donors. Transfusion 2010; 50: 1794-802.
5. Hillgrove T, Moore V, Doherty K, Ryan P,. The impact of temporary deferral due to low hemoglobin: future return, time to return, and frequency of subsequent donation. Transfusion 2011; 51: 539-47.
6. Karp JK, King KE,. International variation in volunteer whole blood donor eligibility criteria. Transfusion 2010; 50: 507-13.
7. ARCBS. Guidelines for the selection of blood donors: Australian Red Cross Blood Service. 2010.
8. Cable RG, Glynn SA, Kiss JE, Mast AE, Steele WR, Murphy EL, Wright DJ, Sacher RA, Gottschall JL, Vij V, Simon TL,; for the NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II). Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion 2011; 51: 511-22.
9. Pasricha SR, Flecknoe-Brown SC, Allen KJ, Gibson PR, McMahon LP, Olynyk JK, Roger SD, Savoia HF, Tampi R, Thomson AR, Wood EM, Robinson KL,. Diagnosis and management of iron deficiency anaemia: a clinical update. Med J Aust 2011; 193: 525-32.
10. Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M,. Immunoassay for human serum hepcidin. Blood 2008; 112: 4292-7.
11. WHO/UNICEF/UNU. Iron deficiency anaemia: assessment, prevention, and control. A guide for programme managers. Geneva: World Health Organization; 2001.
12. Thomas L, Thomas C, Lehmann P, Roeddiger R, Brugnara C,. Iron deficiency, erythropoietic status in anemia, rHuEPO therapy: new diagnostic approaches-the "Thomas-plot." Mannheim: Roche Diagnostics GmbH; 2005.
13. Zhu YI, Haas JD,. Iron depletion without anemia and physical performance in young women. Am J Clin Nutr 1997; 66: 334-41. (Pubitemid 27360332)
14. Brittenham GM, Klein HG, Kushner JP, Ajioka RS,. Preserving the national blood supply. Hematology Am Soc Hematol Educ Program 2001; 422-32.
15. Newman B,. Iron depletion by whole-blood donation harms menstruating females: the current whole-blood-collection paradigm needs to be changed. Transfusion 2006; 46: 1667-81. (Pubitemid 44435718)